Minerva Neurosciences
NERV
24 hedge funds and large institutions have $4.21M invested in Minerva Neurosciences in 2025 Q3 according to their latest regulatory filings, with 5 funds opening new positions, 3 increasing their positions, 4 reducing their positions, and 2 closing their positions.
1,908% more capital inflows, than outflows
Capital inflows: $75.7K | Capital outflows: $3.77K
150% more first-time investments, than exits
New positions opened: 5 | Existing positions closed: 2
14% more funds holding
Funds holding: 21 → 24 (+3)
0.5% more ownership
Funds ownership: 27.81% → 28.31% (+0.5%)
25% less repeat investments, than reductions
Existing positions increased: 3 | Existing positions reduced: 4
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Apella Capital
West Hartford,
Connecticut
|
+$37.6K |
| 2 |
Rangeley Capital
New Canaan,
Connecticut
|
+$20.4K |
| 3 |
Renaissance Technologies
New York
|
+$11.2K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$4.86K |
| 5 |
Carson Wealth (CWM LLC)
Omaha,
Nebraska
|
+$859 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Tower Research Capital (TRC)
New York
|
-$1.79K |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$1.77K |
| 3 |
Jones Financial Companies
Des Peres,
Missouri
|
-$101 |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$63 |
| 5 |
Raymond James Financial
St Petersburg,
Florida
|
-$43 |
NERV Hedge Fund Activity: Q3 2025 in Review
24 of the 7,657 institutional investors tracked by Wall St. Rank reported a position in Minerva Neurosciences (NERV) for Q3 2025, worth a combined $4.21M — up 26% from $3.34M a quarter earlier.
Buyers outnumbered sellers: 5 funds opened new NERV positions and 2 closed out — a net gain of 3 holders — while 3 added to existing stakes and 4 trimmed.
The largest buyer was Apella Capital, adding an estimated $37.6K. The largest seller was Tower Research Capital (TRC), cutting an estimated $1.79K.
- 24 institutional investors held Minerva Neurosciences (NERV) as of Q3 2025, up from 21 in Q2 2025.
- Funds reported $4.21M of Minerva Neurosciences stock for Q3 2025, up 26% quarter-over-quarter.
- 5 funds opened new Minerva Neurosciences positions in Q3 2025 and 2 closed out, a net change of +3 holders.
- The largest Minerva Neurosciences buyer in Q3 2025 was Apella Capital, an estimated $37.6K added.
- The largest Minerva Neurosciences seller in Q3 2025 was Tower Research Capital (TRC), an estimated $1.79K sold.
Based on aggregated 13F filings for Q3 2025.